Neutropenia references

References

RANKIN NE. Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Br Med J. 1953 Apr 25;1(4816):918-9 Article

Hutter RV, Lieberman PH, Collins HS. Aspergillosis in a cancer hospital. Cancer 1964;17:747-56 Article

Mirsky HS, Cuttner J. Fungal infection in acute leukemia. Cancer. 1972 Aug;30(2):348-52 Article

Aisner J, Wiernik PH, Schimpff SC. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med. 1977 May;86(5):539-43 PubMed

Pennington JE. Aspergillus pneumonia in hematologic malignancy. Improvements in diagnosis and therapy. Arch Intern Med. 1977 Jun;137(6):769-71 PubMed

Mahoney DH Jr, Steuber CP, Starling KA, Barrett FF, Goldberg J, Fernbach DJ. An outbreak of aspergillosis in children with acute leukemia. J Pediatr. 1979 Jul;95(1):70-2 Article

Sinclair AJ, Rossof AH, Coltman CA Jr. Recognition and successful management in pulmonary aspergillosis in leukemia. Cancer. 1978 Oct;42(4):2019-24 Article

McGill TJ, Simpson G, Healy GB. Fulminant aspergillosis of the nose and paranasal sinuses: a new clinical entity. Laryngoscope. 1980 May;90(5 Pt 1):748-54 Article

Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 1980 Apr;11(4):370-6 Article

Przyjemski C, Mattii R. The formation of pulmonary mycetomata. Cancer. 1980 Oct 1;46(7):1701-4 Article

Fisher BD, Armstrong D, Yu B, Gold JW. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med. 1981 Oct;71(4):571-7 Article

DeGregorio MW, Lee WM, Linker CA, Jacobs RA, Ries CA. Fungal infections in patients with acute leukemia. Am J Med. 1982 Oct;73(4):543-8 Article

Walsh TJ, Bulkley BH. Aspergillus pericarditis: clinical and pathologic features in the immunocompromised patient. Cancer. 1982 Jan 1;49(1):48-54 Article

Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med. 1984 Jun;76(6):1027-34 Article

Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984 Mar;100(3):345-51 PubMed

Meunier-Carpentier F, Snoeck R, Gerain J, Muller C, Klastersky J. Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. N Engl J Med. 1984 Oct 18;311(16):1056PubMed

Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer. 1984 Feb 1;53(3):411-9 Article

Albelda SM, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Pulmonary cavitation and massive hemoptysis in invasive pulmonary aspergillosis. Influence of bone marrow recovery in patients with acute leukemia. Am Rev Respir Dis. 1985 Jan;131(1):115-20 Article

Dreizen S, Bodey GP, McCredie KB, Keating MJ. Orofacial aspergillosis in acute leukemia. Oral Surg Oral Med Oral Pathol. 1985 May;59(5):499-504 Article

Funada H, Misawa T, Nakao S, Saga T, Hattori KI. The air crescent sign of invasive pulmonary mucormycosis in acute leukemia. Cancer. 1984 Jun 15;53(12):2721-3 PubMed

Gerson SL, Talbot GH, Hurwitz S, Lusk EJ, Strom BL, Cassileth PA. Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med. 1985 Jul;79(1):57-64 Article

Gerson SL, Talbot GH, Lusk E, Hurwitz S, Strom BL, Cassileth PA. Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol. 1985 Aug;3(8):1109-16 Article

Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore). 1985 Jan;64(1):16-35Article

Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology. 1985 Dec;157(3):611-4 Article

Landoy Z, Rotstein C, Shedd D. Aspergillosis of the nose and paranasal sinuses in neutropenic patients at an oncology center. Head Neck Surg. 1985 Nov-Dec;8(2):83-90 Article

McCabe RE, Brooks RG, Mark JB, Remington JS. Open lung biopsy in patients with acute leukemia. Am J Med. 1985 Apr;78(4):609-16 Article

Capnist G, Chisesi T, Battista R, Dini E. Pulmonary aspergillosis complicating aplastic phase in hematologic patients. Haematologica. 1986 May-Jun;71(3):201-4 PubMed

Kahn FW, Jones JM, England DM. The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. Am J Clin Pathol. 1986 Oct;86(4):518-23 Article

Pearson AD, Nesbit ME, Darbyshire PJ, Mott MG. Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia. Pediatr Hematol Oncol. 1986;3(2):153-7PubMed

Schubert MM, Peterson DE, Meyers JD, Hackman R, Thomas ED. Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature. Cancer. 1986 Mar 15;57(6):1092-6 Article

Spearing RL, Pamphilon DH, Prentice AG. Pulmonary aspergillosis in immunosuppressed patients with haematological malignancies. Q J Med. 1986 Jun;59(230):611-25 Article

Stein RS, Greer JP, Ferrin W, Lenox R, Baer MR, Flexner JM. Clinical experience with amphotericin B in acute myelogenous leukemia. South Med J. 1986 Jul;79(7):863-70 Article

Viollier AF, Peterson DE, De Jongh CA, Newman KA, Gray WC, Sutherland JC, Moody MA, Schimpff SC. Aspergillus sinusitis in cancer patients. Cancer. 1986 Jul 15;58(2):366-71 Article

Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med. 1986 Aug;81(2):249-54 Article

Burch PA, Karp JE, Merz WG, Kuhlman JE, Fishman EK. Favorable outcome of invasive aspergillosis in patients with acute leukemia. J Clin Oncol. 1987 Dec;5(12):1985-93 PubMed

Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM. Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr. 1987 May-Jun;11(3):534-6 Article

Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia. The contribution of CT to early diagnosis and aggressive management. Chest. 1987 Jul;92(1):95-9 Article

Meunier F, Leleux A, Gerain J, Ninove D, Snoeck R, Klastersby J. Prophylaxis of aspergillosis in neutropenic cancer patients (Npts) with nasal spray (NS) of amphotericin B (AmB): a prospective randomised study. Abstr. 1346; Interscience Conference on Antimicrobial Agents and Chemotherapy 1987.

Ruutu P, Valtonen V, Elonen E, Volin L, Tukiainen P, Ruutu T. Invasive pulmonary aspergillosis: a diagnostic and therapeutic problem. Clinical experience with eight haematologic patients. Scand J Infect Dis. 1987;19(5):569-75 PubMed

Tricot G, Joosten E, Boogaerts MA, Vande Pitte J, Cauwenbergh G. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Rev Infect Dis. 1987 Jan-Feb;9 Suppl 1:S94-9Article

De Beule K, De Doncker P, Cauwenbergh G, Koster M, Legendre R, Blatchford N, Daunas J, Chwetzoff E. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses. 1988 Sep;31(9):476-85Article

Karp JE, Burch PA, Merz WG. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med. 1988 Aug;85(2):203-6 Article

Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ. Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J (Clin Res Ed). 1988 Apr 9;296(6628):1025-9 Article

Robertson MJ, Larson RA. Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapy. Am J Med. 1988 Feb;84(2):233-9 Article

Schattenberg A, De Vries F, De Witte T, Cohen O, Donnelly JP, De Pauw BE. Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung. Bone Marrow Transplant. 1988 Sep;3(5):509-12 Article

Denning DW, Tucker RM, Hanson LH, Stevens DA. Treatment of invasive aspergillosis with itraconazole. Am J Med. 1989 Jun;86(6 Pt 2):791-800 Article

Jorgensen CJ, Dreyfus F, Vaixeler J, Guyomard S, Massiot C, Belanger C, Brunet F, Giraud T, Dupuis-Camay P. Failure of amphotericin B spray to prevent aspergillosis in granulocytopenic patients. Nouv Rev Fr Hematol. 1989;31(5):327-8 PubMed

Klimowski LL, Rotstein C, Cummings KM. Incidence of nosocomial aspergillosis in patients with leukemia over a twenty-year period. Infect Control Hosp Epidemiol. 1989 Jul;10(7):299-305 Article

Martino P, Raccah R, Gentile G, Venditti M, Girmenia C, Mandelli F. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Haematologica. 1989 May-Jun;74(3):263-5 Article

Potente G. Computed tomography in invasive pulmonary aspergillosis. Acta Radiol. 1989 Nov-Dec;30(6):587-90 PubMed

Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989 Feb 9;320(6):365-76 PubMed

Conneally E, Cafferkey MT, Daly PA, Keane CT, McCann SR. Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplant. 1990 Jun;5(6):403-6 PubMed

Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol. 1990 Sep;23(3 Pt 2):607-14 Article

Martino P, Girmenia C, Venditti M, Micozzi A, Gentile G, Raccah R, Martinelli E, Rendina E, Mandelli F. Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia. Rev Infect Dis. 1990 Jul-Aug;12(4):611-7 Article

Shpilberg O, Douer D, Goldschmied-Reouven A. Block C, Ben Bassat I, Ramot B. Invasive aspergillosis in neutropenic patients with hematological disorders. Leuk Lymphoma 1990;4:257-62.

Wiley JM, Smith N, Leventhal BG, Graham ML, Strauss LC, Hurwitz CA, Modlin J, Mellits D, Baumgardner R, Corden BJ, et al. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. J Clin Oncol. 1990 Feb;8(2):280-6 PubMed

Chopra R, Blair S, Strang J, Cervi P, Patterson KG, Goldstone AH. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. J Antimicrob Chemother. 1991 Oct;28 Suppl B:93-104 Article

Jeffery GM, Beard ME, Ikram RB, Chua J, Allen JR, Heaton DC, Hart DN, Schousboe MI. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. Am J Med. 1991 Jun;90(6):685-92 Article

Kreisel W, Köchling G, von Schilling C, Azemar M, Kurzweil B, Dölken G, Lindemann A, Blum U, Windfuhr M, Müller J. Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Mycoses. 1991 Sep-Oct;34(9-10):385-94 Article

Mori M, Galvin JR, Barloon TJ, Gingrich RD, Stanford W. Fungal pulmonary infections after bone marrow transplantation: evaluation with radiography and CT. Radiology. 1991 Mar;178(3):721-6 Article

Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med. 1991 Nov;91(5):484-92 Article

Talbot GH, Huang A, Provencher M. Invasive aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis. 1991 Mar-Apr;13(2):219-32 Article

Thunnissen PL, Sizoo W, Hendriks WD. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients. Neth J Med. 1991 Aug;39(1-2):84-91 PubMed

Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis. 1992 Mar;14 Suppl 1:S43-53 Article

Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Respir Med. 1992 May;86(3):243-8Article

Weinberger M, Elattar I, Marshall D, Steinberg SM, Redner RL, Young NS, Pizzo PA. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore). 1992 Jan;71(1):24-43 Article

Wong K, Waters CM, Walesby RK. Surgical management of invasive pulmonary aspergillosis in immunocompromised patients. Eur J Cardiothorac Surg. 1992;6(3):138-42; discussion 143 Article

Iwen PC, Reed EC, Armitage JO, Bierman PJ, Kessinger A, Vose JM, Arneson MA, Winfield BA, Woods GL. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol. 1993 Mar;14(3):131-9Article

Martino P, Girmenia C, Micozzi A, Raccah R, Gentile G, Venditti M, Mandelli F. Fungemia in patients with leukemia. Am J Med Sci. 1993 Oct;306(4):225-32 Article

Moreau P, Zahar JR, Milpied N, Baron O, Mahé B, Wu D, Germaud P, Despins P, Delajartre AY, Harousseau JL. Localized invasive pulmonary aspergillosis in patients with neutropenia. Effectiveness of surgical resection. Cancer. 1993 Dec 1;72(11):3223-6 Article

Ribrag V, Dreyfus F, Venot A, Leblong V, Lanore JJ, Varet B. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. Leuk Lymphoma. 1993 Jul;10(4-5):317-21 PubMed

Salonen J, Nikoskelainen J. Lethal infections in patients with hematological malignancies. Eur J Haematol. 1993 Aug;51(2):102-8Article

Todeschini G, Murari C, Bonesi R, Pizzolo G, Amaddi G, Ambrosetti A, Cerù S, Piacentini I, Martini N, Montresor P, et al. Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):614-8 Article

Tollemar J, Ringdén O, Andersson S, Sundberg B, Ljungman P, Sparrelid E, Tydén G. Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplant Proc. 1993 Feb;25(1 Pt 2):1495-7 PubMed

Vreugdenhil G, Van Dijke BJ, Donnelly JP, Novakova IR, Raemaekers JM, Hoogkamp-Korstanje MA, Koster M, de Pauw BE. Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leuk Lymphoma. 1993 Nov;11(5-6):353-8 PubMed

[No authors listed]. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. Working party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother. 1993 Jul;32(1):5-21 Article

Akiyama H, Mori S, Tanikawa S, Sakamaki H, Onozawa Y. Prevention of invasive fungal infection during chemotherapy-induced neutropenia in patients with acute leukemia. Kansenshogaku Zasshi. 1994 Mar;68(3):327-31 Article

Beyer J, Schwartz S, Heinemann V, Siegert W. Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrob Agents Chemother. 1994 May;38(5):911-7 Article

Blum U, Windfuhr M, Buitrago-Tellez C, Sigmund G, Herbst EW, Langer M. Invasive pulmonary aspergillosis. MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest. 1994 Oct;106(4):1156-61 Article

Cordonnier C, Escudier E, Verra F, Brochard L, Bernaudin JF, Fleury-Feith J. Bronchoalveolar lavage during neutropenic episodes: diagnostic yield and cellular pattern. Eur Respir J. 1994 Jan;7(1):114-20 Article

Cowie F, Meller ST, Cushing P, Pinkerton R. Chemoprophylaxis for pulmonary aspergillosis during intensive chemotherapy. Arch Dis Child. 1994 Feb;70(2):136-8 Article

Hertenstein B, Kern WV, Schmeiser T, Stefanic M, Bunjes D, Wiesneth M, Novotny J, Heimpel H, Arnold R. Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol. 1994 Jan;68(1):21-6 Article

Logan PM, Primack SL, Miller RR, Müller NL. Invasive aspergillosis of the airways: radiographic, CT, and pathologic findings. Radiology. 1994 Nov;193(2):383-8 Article

Mills W, Chopra R, Linch DC, Goldstone AH. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol. 1994 Apr;86(4):754-60 Article

O’Donnell MR, Schmidt GM, Tegtmeier BR, et al. Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients. J Clin Oncol 1994; 12:827–34.

Sugata T, Myoken Y, Kyo T, Fujihara M. Invasive oral aspergillosis in immunocompromised patients with leukemia. J Oral Maxillofac Surg. 1994 Apr;52(4):382-6 Article

Verweij PE, Donnelly JP, Kullberg BJ, Meis JF, De Pauw BE. Amphotericin B versus amphotericin B plus 5-flucytosine: poor results in the treatment of proven systemic mycoses in neutropenic patients. Infection. 1994 Mar-Apr;22(2):81-5 Article

Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994 Apr;57(4):1044-50 Article

Behre GF, Schwartz S, Lenz K, Ludwig WD, Wandt H, Schilling E, Heinemann V, Link H, Trittin A, Boenisch O, et al. Aerosol amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in neutropenic cancer patients. Ann Hematol. 1995 Dec;71(6):287-91Article

Böhme A, Ganser A, Hoelzer D. Aggravation of vincristine-induced neurotoxicity by itraconazole in the treatment of adult ALL. Ann Hematol. 1995 Dec;71(6):311-2 Article

Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis. 1995 Mar;20(3):598-605 Article

von Eiff M, Zühlsdorf M, Roos N, Hesse M, Schulten R, van de Loo J. Pulmonary fungal infections in patients with hematological malignancies - diagnostic approaches. Ann Hematol. 1995 Mar;70(3):135-41 Article

Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M, Cudillo L, Cenacchi A, Savignana C, Melillo L. Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Gimema Infection Program (Gruppo Italiano Malat. Br J Haematol. 1995 Mar;89(3):500-5Article

Prentice AG, Warnock DW, Johnson SA, Taylor PC, Oliver DA. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. J Antimicrob Chemother. 1995 Oct;36(4):657-63 Article

Böhme A, Hoelzer D. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients. Mycoses. 1996 Nov-Dec;39(11-12):419-26 Article

Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis. 1996 Sep;23(3):608-15 Article

Lister J. Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience. Eur J Haematol Suppl. 1996;57:18-23 Article

Pagano L, Ricci P, Montillo M, Cenacchi A, Nosari A, Tonso A, Cudillo L, Chierichini A, Savignano C, Buelli M, Melillo L, La Barbera EO, Sica S, Hohaus S, Bonini A, Bucaneve G, Del Favero A. Localization of aspergillosis to the central nervous system among patients with acute leukemia: report of 14 cases. Gruppo Italiano Malattie Ematologiche dell'Adulto Infection Program. Clin Infect Dis. 1996 Sep;23(3):628-30Article

Ruchlemer R, Yinnon AM, Hershko C. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients. Isr J Med Sci. 1996 Nov;32(11):1089-92 PubMed

Bernard A, Caillot D, Couaillier JF, Casasnovas O, Guy H, Favre JP. Surgical management of invasive pulmonary aspergillosis in neutropenic patients. Ann Thorac Surg. 1997 Nov;64(5):1441-7 Article

Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997 Jan;15(1):139-47 Article

Erjavec Z, Woolthuis GM, de Vries-Hospers HG, Sluiter WJ, Daenen SM, de Pauw B, Halie MR. Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur J Clin Microbiol Infect Dis. 1997 May;16(5):364-8 Article

White MH, Anaissie EJ, Kusne S, Wingard JR, Hiemenz JW, Cantor A, Gurwith M, Du Mond C, Mamelok RD, Bowden RA. Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis. 1997 Apr;24(4):635-42 PubMed

Heinemann V, Schwartz S, Behre G, Beyer J. Aerosol amphotericin B for prevention of invasive Aspergillus infections in neutropenic patients - results of a prospective randomised trial. Abstr LM87. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1997: September 28-1 October.

Leenders AC, Daenen S, Jansen RL, Hop WC, Lowenberg B, Wijermans PW, Cornelissen J, Herbrecht R, van der Lelie H, Hoogsteden HC, Verbrugh HA, de Marie S. Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia-associated invasive fungal infections. Br J Haematol. 1998 Oct;103(1):205-12 Article

Martino R, Lopez R, Sureda A, Brunet S, Domingo-Albós A. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature. Haematologica. 1997 May-Jun;82(3):297-304 Article

Morgenstern GR, Prentice AG, Prentice HG. Ropner JE, Schey SA, Warnock DW. Fluconazole vs itraconazole for antifungal prophylaxis in neutropenic patients. Abstr. Trends in Invasive Fungal Infections 4th Barcelona November 5-8th 1997.

Pagano L, Pagliari G, Basso A, Marra R, Sica S, Frigieri L, Morace G, Ardito F, Leone G. The role of bronchoalveolar lavage in the microbiological diagnosis of pneumonia in patients with haematological malignancies. Ann Med. 1997 Dec;29(6):535-40 Article

Tumbarello M, Tacconelli E, Pagano L, La Barbera EO, Morace G, Cauda R, Leone G, Ortona L. Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. J Infect. 1997 Jan;34(1):55-60 Article

Verweij PE, Denning DW. Diagnostic and therapeutic strategies for invasive aspergillosis. Sem Resp Crit Care Med 1997;18:203-215.

Offner F, Cordonnier C, Ljungman P, Prentice HG, Engelhard D, De Bacquer D, Meunier F, De Pauw B. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis. 1998 May;26(5):1098-103 Article

Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis. 1998 Jun;26(6):1383-96 Article

Reichenberger F, Habicht J, Kaim A, Dalquen P, Bernet F, Schläpfer R, Stulz P, Perruchoud AP, Tichelli A, Gratwohl A, Tamm M. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med. 1998 Sep;158(3):885-90 Article

Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) 1998; 77(5):34-54.

Todeschini G, Murari C, Bonesi R, Pizzolo G, Verlato G, Tecchio C et al. Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications. Eur J Clin Invest 1999; 29:453-457.

Yeghen T, Kibbler CC, Prentice HG, Berger LA, Wallesby RK, McWhinney PH, Lampe FC, Gillespie S. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin Infect Dis. 2000 Oct;31(4):859-68 Article

Caillot D, Couaillier JF, Bernard A, Casasnovas O, Denning DW, Mannone L, Lopez J, Couillault G, Piard F, Vagner O, Guy H. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol. 2001 Jan 1;19(1):253-9 Article

Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect. 2001;7 Suppl 2:54-61 Article

Walsh TJ, Goodman JL, Pappas P, Bekersky I, Buell DN, Roden M, Barrett J, Anaissie EJ. Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study. Antimicrob Agents Chemother. 2001 Dec;45(12):3487-96Article

Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002 Aug 8;347(6):408-15 Article

Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer. 2002 Jun 15;94(12):3230-46 Article

Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, Villard O, Liu KL, Natarajan-Amé S, Lutz P, Dufour P, Bergerat JP, Candolfi E. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol. 2002 Apr 1;20(7):1898-906 Article

Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ; Invasive Fungal Infections Coo. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.Clinical Infectious Diseases 2002; 34:7–14Article

Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100:4358–66.

Reichenberger F, Habicht JM, Gratwohl A, Tamm M. diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir j 2002; 19(4):743-55.

Glasmacher A, Prentice A, Gorschluter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.Journal of Clinical Oncology, Vol 21, Issue 24 (December), 2003: 4615-4626Article

Maertens J, Raad I Petrikkos G et al. Update of multicenter noncomparative study of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory (R) or intolerant (I) to other antifungal agents: analysis of 90 patients. Article

Burik JAV, Ratanatharathorn V, Stepan D et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004; 39:1407–1416.

Hope WW, Padwell A, Guiver M, Denning DE. Invasive pulmonary aspergillosis with spontaneous resolution and the diagnostic utility of PCR from tissue specimens. J Infect 2004; 49: 136-140.

Maertens J, Raad I, Petrikkos G, Boogaerts M, Selleslag D, Petersen FB. Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy. Clin Infect Dis 2004; 39:1563-71.

Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004; 190:641-9.

Hope WW, Walsh TJ, Denning DW. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005; 43(1):207-38.

Kontoyiannis DP, Boktour M, Hanna H, Torres HA, Hachem R, Raad II. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005; 103(11):2334-7.

Lass-Flörl, Griff K, Mayr A, Petzer A, GastlG, Bonatti H, Freund M, Kropshofer G, Dierich MP, Nachbaur D. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005; 131(2):201-7.

Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke PF, Bennet JE. The strategy of following voriconazole versus amphotericin B with other licensed antifungal therapy for primary therapy of invasive aspergillosis: Impact of other therpaies on outcome. Clin Infect Dis 2005; 41:1448-52.

Pereira CN, Del Nero G, Lacaz CS, Machado CM. The contribution of galactomannan detection in the diagnosis of invasive aspergillosis in bone marrow transplan recipients. Mycopapthologia 2005; 159(4):487-93.

Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozkan A, Bayran S et al. Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia. Ann Clin Microbiol Antimicrob 2006; 275:17.

Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C et al. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute aspergillosis. J Infect 2006; 53:337-349.

Leather HL, Wingard JR. New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with haematological malignancies. Blood Rev 2006; 20: 267–287.

Maertens J, Glasmacher A, Herbrecht R, et al. Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis. Cancer 2006; 107:2888–97.

Mehta P, Vinks A, Filipovich A et al. High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study. Biol Blood Marrow Transplant 2006; 12: 235–240.

Penack O, Schwartz S, Martus P et al. Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-centre trial. Ann Oncol 2006; 17:1306–1312.

Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006; 42:1417–27.

Singh N, Limaye AP, Forrest G, et al. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation 2006; 81:320–6.

Verweij PE, Mennink-Kersten MASH. Issues with galactomannan testing. Med Mycol 2006; 44(Suppl 1):S179–83.

Yoshida M. Usefulness of determination of B-D-glucan in the diagnosis of deep mycosis. Experience in Japan. Med Mycol 2006; 44:185-189.

Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007; 356:348–59.

Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullman AJ, Bouza E et al. Liposomal amphotericin B as initial therapy for invasive mould infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007:44(10):1289-97.

Cesaro S, Giacchino M, Locatelli F, Spiller M, Buldini B, Castellini C, Caselli D, Giraldi E, Tucci F, Tridello G, Rossi MR, Castagnola E. Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. BMC Infect Dis. 2007; 7:28.

Denning DW. Comparison of two studies of treatment of invasive aspergillosis. Clin Infect Dis 2007; 45:1106-8.

Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al.. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007; 44(3):373-9.

Miceli MH, Maertens J, Buve K, Grazziutti M, Woods G, Rahman M et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description and clinical and research implications. Cancer 2007; 110(1):112-120.

Morrissey CO, Slavin MA, O'Reilly MA, Daffy JR, Seymour JF, Schwarer AP, Szer J. Caspofungin as salvage monotherapy for invasive aspergillosis in patients with haematological malignancies or following allogeneic stem cell transplantation: efficacy and concomitant cyclosporin A. Mycoses. 2007; 50 Suppl 1:24-37.

Pagano L, Caira M, Picardi M, Candoni A, Melillo L, Fianchi L, Offidani M, Nosari A. Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality-SEIFEM-C report. Clin Infect Dis 2007; 44:1524-5.

Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: Outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44:531.

Walsh TJ, Raad I, Patterson TF, et al. Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 2007; 44:2–12.

Bernhard CD, Vassilios D, Hilmar D, Dimitrios M, Georgios B, Friedrich AS. Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients. Interact Cardiovasc Thorac Surg 2008:7; 771-776.

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Kauffman C, Calandra T, Pappas P, Bille J, Denning DW, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Lortholary O, Maertens J, Marr K, Maschmeyer G, Patterson TE, Perfect J, Restrepo J, Ruhnke M, Brahms B, Sobel J, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE. Defining invasive fungal diseases for clinical research: revised definitions of the EORTC/MSG Consensus group. Clin Infect Dis 2008:46:181-21

Dockrell DH. Salvage therapy for invasive aspergillosis. J Antimicrob Chemother 2008; 61(1):41-44.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev 2008; CD007394.

Miceli MH, Grazziutti ML, Woods G, Zhao W, Kocoglu MH, Barlogie B, Anaissie E. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with haematological cancer: Clinical and research implications. Clin Infect dis 2008; 46:1412-22.

NCCN National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 2008; 6:112.

Nivoix Y,  Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Ame S, Fohrer C et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47:1176–1184.

Rijnders BJ, Cornelissen JJ, Slobbe L, Becker MJ, Doorduijn JK, Hop WCJ et al. Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. Clin Infect Dis 2008; 46: 1401-8.

Snelders E, Van der Lee HAL, Kuijpers J, Rijs AJ, Varga J, Samson RA. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008; 5:e219.

Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327–360.

Wingard JR. Learning from our failures: The antifungal treatment conundrum. Clin Infect Dis 2008; 46:1434-5.

Mircescu MM, Lipuma L, van Rooijen N, Pamer EG, Hohl TM. Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection. J Infect Dis 2009; 200(4):647-56.

Lambourne J, Agranoff D, Hrbrecht R, Toke PF, Buchbinder A, Willis F et al. Association of mannose-binding lectin deficiency with acute invasive aspegillosis in immunocompromised patients. Clin Infect Dis 2009; 49(10):1486-91.

Viscoli C, Herbrecht R, Akan H, Baila L, Sonet A, Gallamini A, Giagoundis A, Marchetti O, Martino R, Meert L, Paesmans M, Ameye L, Shivaprakash M, Ullmann AJ, Maertens J; Infectious Disease Group of the EORTC. An EORTC phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother 2009; 64(6):1274-81.

Zaoutis TE, Jafri HS, Huang LM, Locatelli F, Barzilai A, Ebell W, Steinbach WJ, Bradley J, Lieberman JM, Hsiao CC, Seibel N, Laws HJ, Gamba M, Petrecz M, Taylor AF, Strohmaier KM, Chow JW, Kartsonis NA, Ngai AL. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in paediatric patients. Pediatrics 2009; 123(3):877-84.

Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010; 50:1559.

Guinea J, Torres-Narbona M, Gijón P, Muñoz P, Pozo F, Peláez T, de Miguel J, Bouza E. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect. 2010; 16:870-7.

Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C. Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study. Bone Marrow Transplant 2010; 45(7):1227-33.

Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA. Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort. Eur J Clin Microbiol Infect Dis 2010; 29:1387-1394.

M. Aguilar-Guisado, I. Espigado, E. Cordero et al. Empirical antifungal therapy in selected patients with persistent febrile neutropenia. Bone Marrow Transplantation; 2010; 45:159–164.

Nucci M, Nouer SA, Grazziutti M, Kumar NS, Barlogie B, Anaissie E. Probable invasive aspergillosis without prespecified radiologic findings: proposal for inclusion of a new category of aspergillosis and implications for studying novel therapies. Clin Infect Dis. 2010; 51(11):1273-80.

Perkhofer S, Lass-Florl C, Hell M, Russ G, Krause R, Honigl M et al. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int J Antimicrob Ag 2010; 36:531.

Thomas A, Korb V, Guillemain R, Caruba T, Boussaud V, Billaud E, Prognon P, Begué D, Sabatier B. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. J Clin Pharm Ther 2010; 35(1):49-53.

Vallejo C, Len O. Infección fúngica invasora producida por Aspergillus spp. En: Pahissa A, editor. La infección fúngica invasora. Madrid: Entheos; 2010. p. 161–83.

Alison GF, Eric JB, Kent AS, Michael JB, James II, Craig AM, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious diseases society of America. Clinical infectious diseases 2011; 52(4):e56-e93.

Cuenca-Estrella M, Bassetti M, Lass-Florl C, Racil Z, Richardson M, Rogers TR. Detection and investigation of invasive mould disease. J Antimicrob Chemother 2011; 66 (1):15-24.

Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. B-D-Glucan assay for the diagnosis of invasive fungal infections: A meta-analysis. Clin Infect Dis 2011; 52:750-770.

Lamoth F, Rubino I, Bochud PY. Inmunogenetics of invasive aspergillosis. Med mycol 2011; 49(1):125-36.

Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le strat Y et al. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect 2011; 17:1882.

Ok M, Einsele H, Loeffler J. Genetic susceptibility to Aspergillus fumigatus infections. Int J Med Microbiol 2011; 301(5): 445-52.

Ramos ER, Jlang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 2011; 16:1049.

Ruiz-Camps I, Aguado JM, Almirante B, Bouza E, Barbera CF, Len O, et al. Guidelines for the prevention of invasive mould diseases caused by filamentous fungi by the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Microbiol Infect. 2011; 17 Suppl 2:1–24.

Van der Linden JW, Warris A, Verweij PE. Aspergillus species intrinsically resistant to antifungal agents. Med Mycol 2011; 49:82–9

Van der Linden JW, Snelders W, Kampinga GA, Rijnders BJA, Mattsson E, Debets-Ossenkopp YJ, Kuijper EJ, Van Tiel FH, Melchers WJG, Vermeij PE. Clinical implications of azole resistance in Aspergillus fumigatus, the Netherlands, 2007-2009. Emerg Infect Dis 2011; 17(10):1846-54.

Winston DJ, Bartoni K, Territo MC, Schiller GJ. Efficacy, safety and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011; 17(4):507-15.

Aguilar-Guisado M, Martin-Pena A, Espigado I, Ruiz Perez de Pipaon M, Falantes J, de la Cruz F, Cisneros JM. Universal antifungal therapy is not needed in persistent febrile neutropenia: a tailored diagnostic and therapeutic approach. Haematologica 2012; 97(3).

Auberger J, Lass-Florl C, Aigner M, Clausen J, Gastl G, Nachbaur D. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. J Antimicrob Chemother 2012; 67:2268-73.

Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: Human fungal infections. Med Mycol 2012; 4(165).

Dolton MJ, Ray JE, Chen SC, Ng K, Pont L, McLachlan AJ. Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-response relationship and factors affecting concentration. Antimicrob Agents Chemother 2012; 56(11):5503-10.

Fontana C, Gaziano R, Favaro M, Casalinuovo IA, Pistoia ES, Di Francesco P. (1,3)-b-dglucan vs galactomannan antigen in diagnosis invasive fungal infections. Open Microbiol J 2012:6; 70-73.

Herbrechet R, Bories P, Moulin JC, Ledoux MP, Letscher-Bru V. Risk stratification for invasive aspergillosis in immunocompromised patients. Ann NY Acad Sci 2012; 1272:23-30.

Huang X, Chen H, Han M et al. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant Biol Blood Marrow Transplant 2012; 18:1509–1516.

Vallejo Llamas JC, Ruiz-Camps I. Infeccion fungica invasora en los pacientes hematologicos. Enferm infecc microbiol clin 2012; 30(9):572-579.

Kourkoumpetis TK, Fuchs BB, Coleman JJ, Desalermos A, Mylonakis E. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 2012; 54(9):1322-31.

Krishna G, Ma L, Martinho M, O’Mara E. Single-dose phase I study to evaluate the pharmacokinetics of posaconazole in new tablet and capsule formulations relative to oral suspension. Antimicrob Agents Chemother 2012; 56(8):4196-4201.

Lindsey RB, William B, Michael A, Corey C, Erik RD, Alison GF et al. Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 2012; 10:1412-1445.

Wingard JR, Hiemenz JW, Jantz MA. How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation. Blood 2012; 120:1791-1800.

Zou M, Tang L, Zhao S, Zhao Z, Chen L, Chen P et al. Systematic review and meta-analysis of detecting Galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One 2012; 7:433-47.

Cunha C, Aversa F, Romani L, Carvalho A. Human genetic susceptibility to invasive aspergillosis. PLoS Pathog 2013; 9(8).

Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole-resistance Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS pathog 2013; 9(10):e1003633.

European Centre for Disease Prevention and Control. Risk assessment on the impact of environmental usage of triazole on the development and spread of resistance to medical triazoles in Aspergillus species. Stockholm. ECDC 2013.

Espinel-Ingroff A, Chowdhary A, Gonzalez GM, Lass-Flörl C, Martin-Mazuelos E, Meis J, Pelaez T, Pfaller MA, Turnidge J. Multicenter study of isavuconazole MIC distributions and epidemiological cut-off values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method. Antimicrob Agents Chemother 2013; 57(8):3823-8.

Heng SC, Morrissey O, Chen SC-A, Thursky K, Manser RL, Nation RL et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis. Crit Rev Microbiol 2013; 0:1–11.

Howard SJ, Lass-Florl C, Cuenca Estrella M, Gomez-lopez A, Arendrup MC. Determination of isavuconale susceptibility of Aspergillus and Candida species by the EUCAST method. Antimicrob Agents Chemother 2013; 57(11):5426-31.

Kohno S, Izumikawa K, Yoshida M, Takesue Y, Oka S, Kameia K. A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Eur J Clin Microbiol Infect Dis 2013 ;32(3):387-97.

Marcio N, Simone AN, Domenico C, Elias A. Early diagnosis of invasive pulmonary aspergillosis in hematologic patients: an opportunity to improve the outcome. Haematologica. 2013 Nov; 98(11): 1657–1660.

Morrissey CO, Chen SCA, Sorrell TC, Miliken S, Bardy PG, Bradstock KF et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis 2013; 13(6):519-28.

Shakil F, Shaza M, Mohan D, Matthew K, Malcolm R, Sing YS et al. Results of surgery for chronic pulmonary aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence – A National’s Center experience. Eur J Cardiothorac Surg 2013:8; 180.

Thomas JW, Maria NG. Treatment of fungal disease in the setting of neutropenia. Haematology 2013; 423-427.

Zabalza A, Gorosquieta A, Perez-Equiza E, Olavarria E. Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review. Ther Adv Hematol 2013; 4(3):217-230.

Arvanitis M, Ziakas PD, Zacharioudakis IM, Zervou FN, Caliendo AM, Mylonakis E. PCR in diagnosis of invasive aspergillosis: A meta-analysis of diagnostic performance. J Clin Microbiol 2014; 52:3731-3742.

Duarte RF, Sanchez-ortega I, Cuesta I, Arnan M, Patino B, Fernandez de Sevilla A et al. Serum galactomannan based early detection of invasive aspergillosis in haematology patients receiving effective antimould prophylaxis. Clin Infect Dis 2014; 59(12):1696-702.

Lerolle N, Raffoux E, Socie G, Touratier S, Sauvageon H, Porcher R, Bretagne S, Bergeron A, Azoulay E, Molina JM, Lafaurie M. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clin Microbiol Infect 2014; 20(11):952-9.

Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah, May M et al. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy. Intern Med J 2014; 44:1298-1314.

Nucci M, Anaissie E. Haw we treat invasive fungal diseases in patients with acute leukemia: The importance of an individualized approach. Blood 2014; 124 (26):3858-69.

Pagano L, Caira M. The role of primary antifungal prophylaxis in patients with haematological malignancies. Clin Microbiol Infect 2014; 20(6):19-26.

Paola VG, Lucia V, Juan EL, Cesar HC. Treatment of febrile neutropenia and prophylaxis in haematological malignancies: A critical review and update. Advances in haematology 2014; 1-7.

Patterson T, Selleslag D, Mullane KM, et al. A phase 3, randomized, double-blind, non-inferiority trial to evaluate efficacy and safety of isavuconazole versus voriconazole in patients with invasive mold disease (SECURE): outcomes in neutropenic patients [abstract 1210]. In: Program and abstracts of IDWeek, Philadelphia, PA, 2014.

Raad I, Mullane KM, Selleslag D, et al. A phase 3, randomized, double- blind, non-inferiority trial to evaluate efficacy and safety of isavucona- zole vs. voriconazole in patients with invasive mold disease: outcomes in patient with pulmonary infections [abstract 825]. In: Program and abstracts of IDWeek, Philadelphia, PA, 2014.

Aguado JM, Vazquez L, Fernandez-Ruiz M, Villaescusa T, Ruiz-Camps I, Barba P et al Serum galactomannan versus a combination of galactomannan and polymerase chain reaction-based aspergillus DNA detection for early therapy of invasive aspergillosis in high-risk haematological patients: A randomized controlled trial. Clin Infect Dis 2015; 60(30):405-14.

Arvanitis M, Anagnostou, Mylonakis E. Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: A diagnostic mea-analysis. Clin Infect Dis 2015; 61(8):1263-72.

Barchiesi F, Mazzocato S, Mazzanti S, Gesuita R, Skrami E, Fiorentini A, Singh N. Invasive Aspergillosis in Liver Transplant Recipients: Epidemiology, clinical characteristics, treatment and outcomes in 116 cases. Liver Transplant 2015; 21:204.

Cho SY, Lee DG, Choi SM, Choi JK, Lee HJ, Kim SH et al. posaconazole for primary antifungal prophylaxis in patients with acute myelioid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations. Mycoses 2015; 58(9): 565-71.

Denning DW, Bromley MJ. How to bolster the antifungal pipeline. Science 2015; 347:1414-16.

Garcia-Vidal C, Peghin M, Cervera C, Gudiol C, Ruiz-Camps I, Moreno A et al. Causes of death in a contemporary cohort of patients with invasive aspergillosis. PLoS ONE 2015.

Halpern AB, Lyman GH, Walsh TJ, Kontoyiannis DP, Walter RB. Evidence-based focused review of primary antifungal prophylaxis during curative-intnt therapy for acute myeloid leukemia. Blood 2015; 26.

Klingspor L, Saaedi B, Ljungman P, Szakos A. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009). Mycoses 2015; 58:470-477.

Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Postgrad Med J 2015; 91:403-410.

Marr KA, Schlamm HT, Herbrecht R, Rottinghaus ST, Bow EJ, Cornely OA, Heinz WJ, Jagannatha S, Koh LP, Kontoyiannis DP, Lee DG, Nucci M, Pappas PG, Slavin MA, Queiroz-Telles F, Selleslag D, Walsh TJ, Wingard JR, Maertens JA. Combination antifungal therapy for invasive aspergillosis: a randomized trial. Ann Intern Med 2015; 162(2):81-9.

Melinda P, Gabor F, Jozsef K, Laszlo R, Gabor M, Evelin B, Juergen L, Sandor B. Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies and prolonged neutropenia. Infectious diseases 2015; 15:251.

Miceli MH, Kauffman CA. Isavuconazole: A new broad-spectrum triazole antifungal agent. Clin Infect Dis 2015; 61(10):1558-65.

NHS trust. Clinical guideline. Aug 2015.

Raad II, Zakhem AE, Helou GE, Jiang Y, Kontoyiannis DP, Hachem R. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies. Int J Antimicrob Agents. 2015; 45(3):283-8.

Van der Linden JW, Arendrup MC, Warris A, Lagrou K, Pelloux H et al. Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis 2015; 21(6):1041-4.

Verweij PE, Ananda-Rajah M, Andes D, Arendrup MC, Bruggemann RJ et al. International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus. Drug Resist Updat 2015; 21-22:30-40. 

White PL, Barnes RA, Springer J, Klingspor L, Cuenca-Estrella M, Morton CO et al. Clinical performance of aspergillus PCR for testing serum and plasma: a study by the European aspergillus PCR initiative. J Clin Microbiol 2015; 53(9):2832-7.

White PL, Wingard JR, Bretagne S, Loffler J, Patterson TF, Slavin MA et al. Aspergillus polymerase chain reaction: Systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis 2015; 61(8):1293-303.

Wójtowicz A, Bochud PY. Host genetics of invasive Aspergillus and candida infections. Semin Immunopathol 2015; 37(2): 173-86.

Xia D, Sun WK, Tan MM, Zhang M, Ding Y, Liu ZC et al. Aerosolized amphotericin B as prophylaxis for invasive pulmonary aspergillosis: A meta-analysis. Int J Infect Dis 2015; 30:78-84.